These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34015383)

  • 1. Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review.
    Dillard LK; Martinez RX; Perez LL; Fullerton AM; Chadha S; McMahon CM
    J Infect; 2021 Jul; 83(1):27-36. PubMed ID: 34015383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
    Hong H; Dowdy DW; Dooley KE; Francis HW; Budhathoki C; Han HR; Farley JE
    Am J Audiol; 2020 Jun; 29(2):199-205. PubMed ID: 32320639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.
    Hong H; Budhathoki C; Farley JE
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):667-674. PubMed ID: 29862952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in VigiBase® reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment.
    Sagwa EL; Souverein PC; Ribeiro I; Leufkens HG; Mantel-Teeuwisse AK
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):1-8. PubMed ID: 27868278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
    Sogebi OA; Adefuye BO; Adebola SO; Oladeji SM; Adedeji TO
    Auris Nasus Larynx; 2017 Aug; 44(4):404-410. PubMed ID: 27832910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line injectable induced ototoxicity in drug resistant tuberculosis: A systematic review of Indian studies.
    Sarin R; Behera D; Khanna A; Singh V; Narang P; Deepak TS
    Indian J Tuberc; 2019 Apr; 66(2):279-287. PubMed ID: 31151497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.
    Hong H; Dowdy DW; Dooley KE; Francis HW; Budhathoki C; Han HR; Farley JE
    Int J Tuberc Lung Dis; 2020 Jan; 24(1):65-72. PubMed ID: 32005308
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.
    Arnold A; Cooke GS; Kon OM; Dedicoat M; Lipman M; Loyse A; Chis Ster I; Harrison TS
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.
    Hong H; Dooley KE; Starbird LE; Francis HW; Farley JE
    Arch Toxicol; 2019 May; 93(5):1385-1399. PubMed ID: 30963202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.
    Modongo C; Sobota RS; Kesenogile B; Ncube R; Sirugo G; Williams SM; Zetola NM
    BMC Infect Dis; 2014 Oct; 14():542. PubMed ID: 25300708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
    Sagwa EL; Ruswa N; Mavhunga F; Rennie T; Leufkens HG; Mantel-Teeuwisse AK
    BMC Pharmacol Toxicol; 2015 Dec; 16():36. PubMed ID: 26654443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis.
    Wrohan I; Redwood L; Ho J; Velen K; Fox GJ
    Int J Tuberc Lung Dis; 2021 Jan; 25(1):23-30. PubMed ID: 33384041
    [No Abstract]   [Full Text] [Related]  

  • 13. Hearing loss in patients on treatment for drug-resistant tuberculosis.
    Seddon JA; Godfrey-Faussett P; Jacobs K; Ebrahim A; Hesseling AC; Schaaf HS
    Eur Respir J; 2012 Nov; 40(5):1277-86. PubMed ID: 22700838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoglycoside-induced Hearing Loss Among Patients Being Treated for Drug-resistant Tuberculosis in South Africa: A Prediction Model.
    Hong H; Dowdy DW; Dooley KE; Francis HW; Budhathoki C; Han HR; Farley JE
    Clin Infect Dis; 2020 Feb; 70(5):917-924. PubMed ID: 30963176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis.
    Dillard LK; Lopez-Perez L; Martinez RX; Fullerton AM; Chadha S; McMahon CM
    Cancer Epidemiol; 2022 Aug; 79():102203. PubMed ID: 35724557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis.
    Lazarus G; Tjoa K; Iskandar AWB; Louisa M; Sagwa EL; Padayatchi N; Soetikno V
    PLoS One; 2021; 16(3):e0248017. PubMed ID: 33662024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing loss in children treated for multidrug-resistant tuberculosis.
    Seddon JA; Thee S; Jacobs K; Ebrahim A; Hesseling AC; Schaaf HS
    J Infect; 2013 Apr; 66(4):320-9. PubMed ID: 22960077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kanamycin-induced ototoxicity during treatment of multidrug-resistant tuberculosis].
    Poka-Mayap V; Balkissou Adamou D; Pefura-Yone EW; Kuaban C
    Rev Mal Respir; 2020 May; 37(5):369-375. PubMed ID: 32278508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
    Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB
    BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of mitochondrial sequence variants associated with aminoglycoside-induced ototoxicity in South African TB patients on aminoglycosides.
    Human H; Hagen CM; de Jong G; Harris T; Lombard D; Christiansen M; Bardien S
    Biochem Biophys Res Commun; 2010 Mar; 393(4):751-6. PubMed ID: 20171168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.